UKHSA (UK) · Jul 3, 2026
Form: Measles, mumps or rubella (MMR) referral form
MMR diagnostic form (E8): PCR, genotyping and serology tests
Global Health · page 15
UK, EU & international health agencies
DHSC (UK) · Jul 2, 2026
Correspondence: Keep Britain Working review update: March 2026
An update on the implementation of the independent review of the role of employers in tackling health based economic inactivity and promoting healthy and inclusive workplaces.
DHSC (UK) · Jul 2, 2026
Correspondence: Keep Britain Working review update: June 2026
June 2026 update on implementing the independent review of employers' role in tackling health based economic inactivity and promoting healthy and inclusive workplaces.
DHSC (UK) · Jul 2, 2026
NHS patients get faster access to medicines under new pilots
NHS patients could access cutting-edge medicines potentially months earlier under a series of pioneering pilot schemes.
DHSC (UK) · Jul 2, 2026
Transparency data: NHS injury costs recovery scheme: April 2026 to March 2027
Data on the funds collected by the Compensation Recovery Unit and funds paid to the NHS.
MHRA (UK) · Jul 2, 2026
Medicines: apply for a variation to your marketing authorisation
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
DHSC (UK) · Jul 2, 2026
Research: Work-related quality of life of the adult social care workforce in England in 2025
Survey results from the second wave of the Adult Social Care Workforce Survey, undertaken between August and October 2025 in England.
DHSC (UK) · Jul 2, 2026
Guidance: Medicines that you cannot export from the UK or hoard
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
MHRA (UK) · Jul 2, 2026
Making regulation a catalyst, not a barrier, for UK life sciences
MHRA CEO argues that for the UK’s long-term health and prosperity, regulation should help lead, rather than follow, innovation
EMA (EU) · Jul 2, 2026
EMA steps up efforts on medicines for women’s health
EMA is launching initiatives to better embed women’s health considerations in medicines development and regulation. Women live longer than men on average but spend more of their…, Advancing developments in women’s health is one of my personal priorities. This is an area where we are seeing strong momentum at EU and global level, and where EMA is…, EMA’s initiatives in this area will be discussed through a dedicated women’s health workshop on 28-29 September. The workshop, broadcast live, will take stock of current…
UKHSA (UK) · Jul 2, 2026
Guidance: Rare and Imported Pathogens Laboratory (RIPL): user manual
Information for clinicians and referring laboratories about the range of tests offered by the Rare and Imported Pathogens Laboratory (RIPL).
DHSC (UK) · Jul 2, 2026
Guidance: Safeguarding UK human genomic data
Guidance setting clear expectations for how human genomic data is made available to approved users.
MHRA (UK) · Jul 2, 2026
Research: MHRA data requirements to support regulatory decision making
A regulator’s view on what the new UK Health Data Research Service must deliver.
UKHSA (UK) · Jul 2, 2026
Research: Sexually transmitted infections: London data
Reports presenting data since 2014 for sexually transmitted infections (STIs) in London.
DHSC (UK) · Jul 2, 2026
Official Statistics: Adult social care client level data, England: quarterly update to March 2026
Official statistics in development on insights from client level data from local authorities, including information on assessments and long-term support.
UKHSA (UK) · Jul 2, 2026
Official Statistics: Respiratory syncytial virus (RSV) maternal vaccination coverage in England
Official statistics data and reporting on vaccine uptake for the RSV (respiratory syncytial virus) vaccination programme for pregnant women.
UKHSA (UK) · Jul 2, 2026
Official Statistics: National norovirus and rotavirus surveillance reports: 2025 to 2026 season
Reports of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in hospital settings in England during the 2025 to 2026 season.
UKHSA (UK) · Jul 2, 2026
Official Statistics: Respiratory syncytial virus (RSV) older adults vaccination coverage in England
Vaccine uptake data for the respiratory syncytial virus (RSV) vaccination programme for older adults.
UKHSA (UK) · Jul 2, 2026
Guidance: Pre-release access lists: National norovirus and rotavirus surveillance reports
Lists of those receiving pre-release access to UK Health Security Agency national norovirus and rotavirus surveillance reports
MHRA (UK) · Jul 2, 2026
Borderline products: how to tell if your product is a medicine
How the MHRA makes decisions on what is a medicinal product (borderline products).
MHRA (UK) · Jul 2, 2026
Decision: Human medicines: register of electronic export certificates
Department of Health and Social Care and MHRA register of electronic export certificates (human).
MHRA (UK) · Jul 1, 2026
Medicines: packaging, labelling and patient information leaflets
How to package medicines for sale and what information you must provide to consumers and healthcare professionals.
MHRA (UK) · Jul 1, 2026
Guidance: Warning statements for labels and leaflets of certain medicines
This guidance sets out the warning statements which should appear on the label and/or in the leaflet of certain medicines.
MHRA (UK) · Jul 1, 2026
Guidance: Best practice guidance on patient information leaflets
This guidance sets out the legal framework for patient information leaflets as described in EU and national legislation and best practice in the area of information design.